Han, Xue <br/><br/>
Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Feb 2019 
 - 303-312 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-018-2758-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>B7-H1 Antigen--blood<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Hepatocellular--blood<br/>Case-Control Studies<br/>Female<br/>Follow-Up Studies<br/>Hepatitis B--complications<br/>Hepatitis B virus--isolation & purification<br/>Humans<br/>Immunotherapy--mortality<br/>Liver Neoplasms--blood<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Survival Rate